Cholesterol Lipids of Borrelia burgdorferi Form Lipid Rafts and Are Required for the Bactericidal Activity of a Complement-Independent Antibody  by LaRocca, Timothy J. et al.
Cell Host & Microbe
ArticleCholesterol Lipids of Borrelia burgdorferi Form
Lipid Rafts and Are Required for the Bactericidal
Activity of a Complement-Independent Antibody
Timothy J. LaRocca,1 Jameson T. Crowley,1 Brian J. Cusack,1 Priyadarshini Pathak,2 Jordi Benach,3 Erwin London,2
Juan C. Garcia-Monco,1 and Jorge L. Benach1,*
1Department of Molecular Genetics and Microbiology, and Center for Infectious Diseases
2Department of Biochemistry and Cell Biology
Stony Brook University, Stony Brook, NY 11794, USA
3ALBA Synchrotron Light Source (CELLS) Cerdanyola del Valle`s, 08290 Barcelona, Spain
*Correspondence: jbenach@notes.cc.sunysb.edu
DOI 10.1016/j.chom.2010.09.001SUMMARY
Borrelia burgdorferi, the agent of Lyme disease, is
unusual as it contains free cholesterol and choles-
terol glycolipids. It is also susceptible to comple-
ment-independent bactericidal antibodies, such as
CB2, a monoclonal IgG1 against outer surface
protein B (OspB). We find that the bactericidal
action of CB2 requires the presence of cholesterol
glycolipids and cholesterol. Ultrastructural, bio-
chemical, and biophysical analysis revealed that
the bacterial cholesterol glycolipids exist as lipid
raft-like microdomains in the outer membrane of
cultured and mouse-derived B. burgdorferi and in
model membranes from B. burgdorferi lipids. The
order and size of the microdomains are temperature
sensitive and correlate with the bactericidal activity
of CB2. This study demonstrates the existence of
cholesterol-containing lipid raft-like microdomains
in a prokaryote, and we suggest that the temperature
dependence of B. burgdorferi lipid raft organization
may have significant implications in the transmission
cycle of the spirocheteswhich are exposed to a range
of temperatures.
INTRODUCTION
The Borrelia include the agents of Lyme disease (Benach et al.,
1983; Burgdorfer et al., 1982) and relapsing fever (Johnson,
1977) and are extracellular spirochetes that are susceptible to
antibodies (Connolly and Benach, 2005; LaRocca and Benach,
2008). The antibody response is the primary means of host
defense against the Borrelia and is linked to the pathogenesis
of these infections. Antibodies were first used to confirm the
spirochetal etiology of Lyme disease, and serology is critical
for diagnosis of the disease.
Lytic complement is not required for clearance of Borrelia
infections (Bockenstedt et al., 1993; Connolly and Benach,
2001; Newman and Johnson, 1981), and resistance to comple-Cell Hosment is mediated by the binding of complement regulator
inhibitors (Bykowski et al., 2008). There are complement-inde-
pendent antibodies to Borrelia that are bactericidal in vitro and
in vivo. The monoclonal antibodies CB2 (IgG1) and H6831
(IgG2a) against the outer surface lipoprotein B (OspB) of
B. burgdorferi and CB515 (IgM) and H4825 (IgG2a) against vari-
able major proteins (Vmps) of relapsing fever Borrelia exhibit this
unique bactericidal activity (Coleman et al., 1992; Connolly et al.,
2004; Sadziene et al., 1993). Fab fragments and the variable
regions alone had the same effect (Coleman et al., 1992;
Sadziene et al., 1993; LaRocca et al., 2008). Structural changes
occur in OspB upon binding of CB2 or H6831 (Becker et al.,
2005; Katona et al., 2000).
Complement-deficient mice generated IgM antibodies coinci-
dent with the clearance of relapsing fever spirochetemia
identical to wild-type (WT) mice (Connolly and Benach, 2001;
Connolly et al., 2004). B cell-deficient mice had a peak spiroche-
temia that was longer and higher than that of WT mice. These
experiments demonstrated that complement-independent
bactericidal antibodies function in vivo. CB2 creates pores that
lead to osmotic lysis as part of its bactericidal mechanism
(LaRocca et al., 2009). Exposure to CB2 resulted in the creation
of outer membrane projections and openings. Additionally, CB2
bound to E. coli expressing OspB was not bactericidal, indi-
cating that factors specific to the Borrelia outer membrane
are required for the bactericidal mechanism (LaRocca et al.,
2009).
The outer membrane of Borrelia contains phosphatidylcholine
and phosphatidylglycerol, as well as numerous lipoproteins
(Belisle et al., 1994; Brandt et al., 1990; Jones et al., 1995; Radolf
et al., 1994, 1995). Incorporation of cholesteryl glucoside into the
membrane of B. hermsii (Livermore et al., 1978) prompted the
demonstration that B. burgdorferi also contained antigenic
glycolipids (Wheeler et al., 1993). Antibodies to these glycolipids
crossreact with gangliosides, and vice versa (Garcı´a Monco´
et al., 1993; Garcia-Monco et al., 1995).
B. burgdorferi has three glycolipids, two of which contain
cholesterol. These glycolipids were identified as cholesteryl
6-O-acyl-b-D-galactopyranoside or cholesteryl 6-O-palmitoyl-
b-D-galactopyranoside (ACGal/Bb-GL-I), cholesteryl-b-D-gal-
acto-pyranoside (CGal), and mono-a-galactosyl-diacylglycerol
(MGalD) and exist in other Borrelia species (Ben-Menachemt & Microbe 8, 331–342, October 21, 2010 ª2010 Elsevier Inc. 331
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cholesterol and cholesterol esters also exist in the outer
membrane of Borrelia (Stu¨bs et al., 2009). The presence of
cholesterol and cholesterol glycolipids in prokaryotes is unusual,
although there are some exceptions such as Helicobacter,
Mycoplasma, Ehrlichia, Anaplasma, and Brachyspira (Haque
et al., 1995; Hirai et al., 1995; Lin and Rikihisa, 2003; Smith,
1971; Trott et al., 2001). In eukaryotic cell membranes, sterols
help form microdomains called lipid rafts (Brown and London,
2000; London, 2002). Lipid rafts are ordered, rigid, cholesterol-
rich areas of the membrane that have lipid-anchored proteins,
notably the glycosylphosphatidylinositol (GPI)-anchored pro-
teins that have important roles in maintaining lateral heterogene-
ities in cell membranes and in biological sorting processes. Lipid
rafts are important for receptor clustering and lateral sorting of
proteins (Brown, 1998; Epand, 2008), as well as elasticity, endo-
cytosis, exocytosis, and vesicle formation and budding (Chen
and Rand, 1997; Nichols, 2003; Salau¨n et al., 2004; Wang
et al., 2000). The presence of cholesterol in the outer membrane
of Borrelia suggests that lipid raft microdomains, similar to those
in eukaryotes, may exist in these bacteria. If this is the case, lipid
rafts may be important for lateral sorting and coalescence of
certain Borrelia antigens and could influence membrane effects
in response to CB2.
We show here that cholesterol and cholesterol glycolipids are
critical for the bactericidal mechanism of the complement-inde-
pendent mAb, CB2. We also show evidence for the existence of
lipid raft microdomains in B. burgdorferi.
RESULTS
CB2 Causes Removal of Antigens from the Surface
of B. burgdorferi in Membrane Vesicles
CB2 exerts its bactericidal effects by creating membrane projec-
tions and blebs on the surface of B. burgdorferi, and we
proposed that vesicle removal formed the lytic pores (LaRocca
et al., 2009). To determine whether vesicle removal is important
in the bactericidal mechanism of CB2, we measured release of
vesicles in Borrelia supernatants with the fluorescent, lipophilic
probe 1,6-diphenyl-1,3,5-hexatriene (DPH). DPH fluoresces in
hydrophobic but not aqueous environments and shows a linear
response with membrane bilayer concentration (London and
Feligenson, 1978). Spirochetes were treated with CB2, CB10,
or a control without antibody in the presence of dextran T500
to prevent lysis (LaRocca et al., 2009). Greater release of vesicles
from CB2-treated B. burgdorferi was observed relative to the
controls that had the normal, constitutive level of membrane
vesicle release (Figure 1A). Vesicle release was correlated with
an increased release of OspB and OspA but not of cytosolic
DnaK (Figure 1B). Negative-stain transmission electron micros-
copy (TEM) demonstrated removal of membrane vesicles that
contained OspB (Figure 1C). The membrane vesicles also con-
tained OspA, concordant with our earlier observations with
confocal microscopy where we observed release of vesicles
containing OspA as a later event in the bactericidal mechanism
after release of vesicles containing OspB (Escudero et al.,
1997). The late release of vesicles containing OspA may be
due to the lack of membrane stability induced by the binding
of CB2 to OspB.332 Cell Host & Microbe 8, 331–342, October 21, 2010 ª2010 ElsevieThe release of vesicles caused by CB2 suggested that choles-
terol and cholesterol glycolipids could be constituents of these
structures, and they were quantified in supernatants after CB2
treatment. Polyclonal rabbit anti-asialo GM1 cross-reacts with
B. burgdorferi cholesterol glycolipids and was used to detect
the cholesterol glycolipids in the vesicles induced by treatment
with CB2 (Figure 1D). When these supernatants were resolved
by electrophoresis on native gels and transferred to nitrocellu-
lose, immunoblot reactivity to OspB, OspA, and cholesterol
glycolipids occurred at the same mobility, but not DnaK (Fig-
ure 1E), confirming the inclusion of the lipoproteins in the mem-
brane vesicles and also the results in Figures 1B and 1D.
Cholesterol Is Required for the Bactericidal Mechanism
of CB2
The possibility of a molecular interaction between OspB and
cholesterol glycolipids led us to test whether the bactericidal
mechanism of CB2 is dependent on cholesterol. Methyl-b-cyclo-
dextrin (MbCD) has been used to deplete cholesterol in eukary-
otic cells (Zidovetzki and Levitan, 2007) and bacteria (Lin and Ri-
kihisa, 2003). Given the known toxicity of MbCD, we determined
the experimental conditions for its use. There was no change in
spirochete numbers after an MbCD exposure of 3 hr (Figure 2A),
and spirochetes exposed to 10 mM MbCD for 30 min grew nor-
mally once returned to normal medium (Figure 2B). Protein
levels did not change in the pellet or supernatant after MbCD
treatment for 1 hr (Figure S1A available online). Furthermore,
addition of cholesterol was not toxic as exposure to 10 and
20 mg/ml of excess cholesterol did not affect spirochete growth
(Figure 2B). These experiments show that there are no obvious
pleiotropic effects of MbCD or of excess cholesterol at the
concentrations and incubation times used for the cholesterol-
depletion experiments, and that the spirochetes remain viable
(do not lyse). When B. burgdorferi were treated with 10 mM
MbCD for 30 or 60 min, there was a 50% reduction in total
cholesterol detected fluorometrically (Figure 2C). Lipid extracts
from supernatants and pellets of MbCD-treated spirochetes
were separated by thin-layer chromatography (TLC) and showed
that MbCD removes free cholesterol, and the glycolipids ACGal/
Bb-GL-I and CGal from B. burgdorferi while not affecting MGalD
or phospholipids (Figure 2D). Probing MbCD-treated superna-
tants with antibody to asialo GM1 in immunoblots confirmed
that cholesterol glycolipids were removed from B. burgdorferi
(Figure 2D). Lipid extracts were also analyzed by mass spec-
trometry, which showed that MbCD removed the two cholesterol
glycolipids and confirmed the TLC findings (Table S1).
To determine the role of cholesterol and cholesterol glyco-
lipids in the bactericidal mechanism of CB2, we pretreated spiro-
chetes with MbCD for 30 min and exposed them to the antibody.
In contrast to the 50% decrease in organisms without MbCD
treatment, after a 15 min incubation with CB2, there was no
reduction (Figure 2E). Spirochetes depleted of cholesterol ex-
hibited decreased vesicle release after CB2 treatment compared
to controls (Figure 2F). The difference in vesicle release resulting
from treatment with CB2 or CB10 may be due to the greater
affinity of CB2 for OspB. The affinity of CB2 for recombinant
OspB is three orders of magnitude greater (Kd = 1.1 nM) than
the affinity of CB10 for recombinant OspA (Kd = 1.6 mM). Thus,
membrane cholesterol enhances the bactericidal action of CB2.r Inc.
Figure 1. CB2 Removes Antigens from the
Surface of B. burgdorferi in Membrane
Vesicles
(A) CB2 treatment caused increased release of
membrane vesicles from B. burgdorferi relative
to treatment with CB10 (control IgG against
OspA) or no antibody (Ab) as measured by DPH
fluorescence in the cell-free supernatant (sup).
(B) Immunoblots showing that OspB and OspA
are released into the supernatant upon CB2 treat-
ment for 15 min or 1 hr while the cytosolic DnaK
is not.
(C) Negative-stain TEM images showing that
CB2 causes removal of OspB and OspA (18 nm
colloidal gold) from the surface in large and small
membrane vesicles (dark gray around colloidal
gold) after 15 min of exposure. Controls
(secondary colloidal gold conjugate only) did not
show labeling. Scale bars represent 500 nm.
(D) ELISA showing greater release of cholesterol
glycolipids into the supernatant (see A).
(E) Native PAGE immunoblot of supernatants from
spirochetes treated with CB2 for 30 min. Bands
representing OspB, OspA, and cholesterol glyco-
lipids (anti-asialo GM1) had the same mobility
(arrow), indicating colocalization of these mole-
cules in CB2-induced vesicles; cytosolic DnaK
was not present in the supernatant.
Results in (A), (B), (D), and (E) are from triplicate
experiments. ANOVA, ***p < 0.001. Error bars
represent the standard deviation.
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specific for cholesterol depletion, wemixedMbCDwith 20 mg/ml
cholesterol prior to treatment of spirochetes, followed by CB2
treatment. Spirochete numbers decreased to levels similar
to treatment with CB2 alone (Figure 3A). We next assessed
the bactericidal effect of CB2 when cholesterol was replaced
after depletion. Cholesterol replacement was confirmed by
incorporation of the fluorescent NBD-cholesterol into B. burg-
dorferi after MbCD treatment (Figure 3B). Replacing cholesterol
in spirochetes resulted in its incorporation into the cholesterol
glycolipid fraction as detected with anti-asialo GM1 in slot
blots (Figure 3B). Cholesterol replacement also restored the
bactericidal effect of CB2 (Figure 3C). Furthermore, addition ofCell Host & Microbe 8, 331–342,20 mg/ml exogenous cholesterol during
CB2 treatment enhanced the bactericidal
effect (Figure 3D). To determine whether
cholesterol replacement or deletion
have an effect on CB2 binding to OspB,
we performed surface labeling of OspB
by indirect immunofluorescence of
B. burgdorferi and western blots quanti-
tated by densitometry. Using both exper-
imental approaches, we concluded that
the binding of CB2 to OspB after choles-
terol replacement or deletion does not
change, indicating that the accessibility
of OspB to the antibody remains the
same (Figures S1B and S1C). Theseexperiments show that membrane cholesterol is required for
the bactericidal mechanism of CB2.
The Cholesterol Glycolipids of B. burgdorferi Are
Constituents of the Membrane Vesicles Created by CB2
The localization of the cholesterol glycolipids in relation to OspB
was characterized with transmission electron microscopy (TEM)
after treatment of spirochetes with CB2. An anti-rabbit IgG
conjugated to colloidal gold of 6 nm was used to detect anti-
asialo GM1 bound to cholesterol glycolipids and an anti-mouse
IgG conjugated to colloidal gold of 18 nm was used to detect
CB2 bound to OspB (Figure 4). There was an abundance of
cholesterol glycolipids in outer membrane projections createdOctober 21, 2010 ª2010 Elsevier Inc. 333
Figure 2. Cholesterol Depletion Affects the Bactericidal Mechanism of CB2 against B. burgdorferi
(A) Ten millimolar MbCD is not toxic to B. burgdorferi after a 3 hr exposure.
(B) Left:B. burgdorferi grow normally after cholesterol depletion withMbCD for 30min (black diamonds) compared to untreated spirochetes (gray squares). Right:
no difference in the growth of B. burgdorferi with 10 (dark gray squares), or 20 mg/ml (light gray squares) of excess cholesterol; controls (black diamonds).
(C) Ten millimolar MbCD depletes cholesterol in B. burgdorferi by 50% after 30 or 60 min of treatment.
(D) Left: chloroform-methanol (85:15) TLC showing that MbCD removes cholesterol (Cho) and cholesterol glycolipids (ACGal, CGal) into the supernatant (SUP),
while the MbCD-treated B. burgdorferi pellet (PEL) contains ACGal, MGalD (cholesterol-free glycolipid), phosphatidyl choline (PC), and phosphatidyl glycerol
(PG). Right: immunoblot of supernatants (sup) from control or MbCD-treated spirochetes probedwith anti-asialo GM1 confirming thatMbCD removes the choles-
terol glycolipids.
(E) Spirochetes were exposed to MbCD for cholesterol depletion and then treated with CB2 or the control IgG CB10 for 15 min.
(F) DPH fluorescence vesicle assay of spirochete supernatants shows that depletion of cholesterol with MbCD reduces the number of vesicles released from
B. burgdorferi upon CB2 exposure. Spirochete counts were done by direct dark-field microscopy enumeration.
Results for (A)–(C), (E), and (F) are from triplicate experiments. ANOVA, ***p < 0.001, **p < 0.01. Error bars represent the standard deviation. See also Table S1 and
Figure S1.
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taining OspB and bound CB2 (Figures 4A–4D), demonstrating
the presence of these lipids in the released structures. The
cholesterol glycolipids formed distinct clusters or microdomains
surrounding OspB in membrane vesicles and projections.334 Cell Host & Microbe 8, 331–342, October 21, 2010 ª2010 ElsevieThe Cholesterol Glycolipids of B. burgdorferi Bind OspB
The clustering of cholesterol glycolipids around OspB in the
outer membrane and in released vesicles (Figure 4) shows that
these molecules associate and that OspB exists in microdo-
mains in the outer membrane of B. burgdorferi. It is possibler Inc.
Figure 3. Cholesterol Is Required for the
Bactericidal Mechanism of the Comple-
ment-Independent Antibody, CB2
(A) Inhibition of 10 mM MbCD with 20 mg/ml of
soluble cholesterol (+ MbCD/Cho) restored the
bactericidal effect of CB2.
(B) Top: spirochetes exposed to 10 mM MbCD
and treated with the fluorescent cholesterol-
NBD show that cholesterol has been reincorpo-
rated into their membrane. Bottom: slot blot
shows that cholesterol replacement results in its
incorporation in the cholesterol glycolipids as
detected by anti-asialo GM1.
(C) CB2 regains its bactericidal effect against
spirochetes that have had their cholesterol re-
placed after depletion (MbCD + Cho).
(D) Addition of excess cholesterol (20 mg/ml, +
Cho) during CB2 treatment enhances the bacteri-
cidal effect of the antibody against spirochetes.
Results for (A), (C), and (D) are from triplicate
experiments. ANOVA, ***p < 0.001, **p < 0.01.
Error bars represent the standard deviation. See
also Figure S1.
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interaction of its covalently linked palmitates with the tightly
packed hydrophobic core of the ordered domains, as is the
case for other lipid-anchored proteins that interact with lipid
rafts. Crystal structures of both OspA and OspB share a putative
binding cleft for which there is no proposed ligand (Becker et al.,
2005; Li et al., 1997). At the bottom of this cleft are three charged
amino acids (arg-162, glu-184, and arg-214) that may be func-
tionally important as a result of their location and sequence
conservation. It has been postulated that this cleft could bind
small molecules, so we tested whether the cholesterol glyco-
lipids bind to this cleft. Blind docking analyses with the program
VINA were performed with the crystal structure of OspB and
ACGal, Bb-GL-I, and CGal. The top-scored binding sites in
OspB were those involving the cleft lined with the previously
mentioned triad of arg-162, glu-184, and arg-214. The binding
energy calculated in silico by VINA of the top ranking
solution of each docked complex at 25C was 6.5 kcal/mol
(Ki 17 mM) for ACGal, 7.3 kcal/mol (Ki 4 mM) for CGal, and
5.4 kcal/mol for Bb-GL-I (Ki109 mM). However, the conforma-
tions adopted by these molecules, the weak hydrogen bond and
steric interactions with OspB and the extended solvent exposure
of these hydrophobic molecules, point to a weak interaction of
these cholesterol glycolipids with the OspB cleft, consistent
with the relatively low binding energies (Figure S2). This suggests
that the cleft in OspB has low affinity for the cholesterol glyco-
lipids of B. burgdorferi, although it could also be enhanced if
OspB is held in the outer membrane by other interactions. Dock-
ing analyses and modeling show that the glycolipid binding site
faces the membrane and that it would be relatively near to its
surface (30–40 A˚). Furthermore, the N terminus of OspB is
close to the cleft, and in all the binding models predicted by theCell Hosdocking analyses, the cleft faces the cellular membrane (Fig-
ure S2, arrow) which strengthens the possibility of an interaction.
Detergent Resistant Membranes Containing OspB
and Cholesterol Glycolipids Can Be Isolated
from B. burgdorferi
The clustering of cholesterol into distinctmicrodomains (Figure 4)
is a characteristic of lipid rafts. To determine whether the choles-
terol glycolipid-rich regions of B. burgdorferi exhibit other char-
acteristics of lipid rafts, we performed solubilization experiments
withB. burgdorferiwith Triton X-100 (TX-100) at 4C, followed by
separation of the lysate on a discontinuous OptiPrep density
gradient. Lipid rafts resist solubilization by TX-100 at 4C, form-
ing detergent-resistant membranes (DRMs) (Brown and Rose,
1992). DRMs float in the gradient and are found at the 25%
density with some at 20% and 30%. Each density fraction was
analyzed by slot blot for cholesterol glycolipids, as well as
specific proteins that may associate with the DRMs. Cholesterol
glycolipids were concentrated in the 25% and 30% fractions
with some in the 20% fraction, demonstrating association of
these glycolipids with DRMs (Figure 5A). The outer membrane
proteins OspB, OspA, and P66 partitioned with cholesterol
glycolipids in the DRMs in the 20%, 25%, and 30% fractions,
suggesting that these proteins normally reside in lipid rafts
(Figure 5A). The cytoplasmic Lon-1 protease (Coleman et al.,
2009) was included as a control and was only found in the
35% fraction, typical for a soluble protein (Figure 5A). We also
determined the lipid composition of the DRM and non-DRM
(solubilized) fractions. We found that TX-100 treatment solubi-
lized PC, PG, and MGalD but not ACGal/Bb-GL-I, CGal, or free
cholesterol when lipids were analyzed by TLC (Figure S3). This
result shows that the DRMs are composed of a distinct subsett & Microbe 8, 331–342, October 21, 2010 ª2010 Elsevier Inc. 335
Figure 4. The Cholesterol Glycolipids of B. burgdorferi Are Constituents in the Projections and Vesicles Induced by CB2
Negative-stain TEM images of CB2-treated B. burgdorferi that were labeled with immunogold for CB2 bound to OspB (18 nm colloidal gold) and cholesterol
glycolipids (6 nm colloidal gold). Cholesterol glycolipids are associated with projections (A–C) and vesicles (B–D) induced by CB2. (D) specifically focuses on
released membrane vesicles. Projections and released vesicles contain cholesterol glycolipids clustered around OspB (arrows), suggesting the existence of
cholesterol-rich microdomains. Controls included secondary gold conjugates alone and normal mouse and rabbit serum controls. Scale bars represent
100 nm. See also Figure S2.
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lated from B. burgdorferi and that they are rich in cholesterol
lipids is suggestive of the existence of lipid rafts. Indeed, after
cholesterol depletion of spirochetes that disrupts lipid rafts,
and thus the DRMs, the same lipoproteins solubilize and are
found in the 35% fraction (Figure 5B).
Multilamellar Vesicles of B. burgdorferi Lipids
Spontaneously Form Ordered Lipid Domains
To confirm that the insolubility of B. burgdorferi lipids in TX-100
was linked to their ability to form ordered domains (lipid rafts),
we studied the properties of multilamellar vesicles (MLVs)
composed of extracted B. burgdorferi lipids and compared
them to those of vesicles forming a raft (liquid ordered, Lo) state
or a nonraft (liquid disordered, Ld) state. Figure 5C shows that
DRMs can be obtained by treating B. burgdorferi MLVs with336 Cell Host & Microbe 8, 331–342, October 21, 2010 ª2010 ElsevieTX-100 at room temperature (RT). The degree of insolubility in
TX-100 is slightly less than that of sphingomyelin/cholesterol
vesicles (SM/cho 2:1), which form the Lo state, and much
more than for dioleoylphosphatidylcholine /cholesterol vesicles
(DOPC/cho 2:1), which form the Ld state. DPH fluorescence
anisotropy measurements (for membrane order) indicated that
at RT the degree of order in theB. burgdorferiMLVswas interme-
diate between Lo state SM/cho and Ld state DOPC/cho
(Figure 5D). This shows that the tendency of B. burgdorferi lipids
to form an ordered state bilayer is not a detergent artifact.
Measurement of temperature dependence of fluorescence
anisotropy (Figure 5E) shows that the high degree of order in
Borrelia lipids relative to that in nonraft (DOPC/cho) vesicles
persists to high temperatures.
Although detergent-resistance and anisotropy experiments
demonstrate a degree of lipid order, they do not distinguishr Inc.
Figure 5. Lipid Rafts Exist in B. burgdorferi
(A) Whole spirochetes were subjected to TX-100
treatment at 4C and Optiprep density gradient
separation. Gradient fractions were slot blotted
and probed with anti-asialo GM1, OspB, OspA,
P66, or Lon-1 protease.
(B) Spirochetes were treated as in (A) but were
exposed to 10 mM MbCD prior to solubilization
in TX-100. Cholesterol depletion leads to solubili-
zation of lipoproteins (35% fraction).
(C) B. burgdorferi lipids in the form of MLV model
membranes display resistance to solubilization by
TX-100. Lipid ratios are mol:mol. SM/cho (2:1) Lo,
sphingomyelin/cholesterol vesicles; DOPC/cho
(2:1) Ld, dioleoylphosphatidylcholine /cholesterol
vesicles.
(D) Fluorescence anisotropy of DPH demon-
strates a high degree of order among lipids in
B. burgdorferi MLVs.
(E) DPH fluorescence anisotropy in BorreliaMLVs
as a function of temperature. MLVs contained
B. burgdorferi lipid extract (filled circles) or 2:1
DOPC/cholesterol (open circles). Open squares
show the difference between the value forBorrelia
lipids and that for the DOPC/cho fit to a sigmoidal
curve that has a limiting value of zero at high
temperature.
(F) FRET as a function of temperature for Borrelia
lipids in model membranes demonstrates the
coexistence of Lo (raft) and Ld domains (high
F/Fo values). MLVs contained Borrelia lipid
extract (open circles) or DOPC/cholesterol 2:1
(filled circles). F/Fo is the ratio of fluorescence in
samples containing donor (NBD-DPPE) and
acceptor (rhodamine-DOPE) to that in samples
containing donor.
(A) and (B) are representative experiments, and
(C)–(F) are from triplicate experiments. *p < 0.05,
***p < 0.001. Error bars represent the standard
deviation. See also Figure S3.
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degree of order and one that contains coexisting Lo (raft) and
Ld domains. To distinguish this, a Fo¨rster resonance energy
transfer (FRET) assay was used. This evaluates the degree of
segregation of NBD-1,2-dipalmitoyl-sn-glycero-3-phosphoe-
thanolamine-N-7-nitro-2-1,3-benzoxadiazol-4-yl (NBD-DPPE),
which has a moderate affinity for rafts, and 1,2-dioleoyl-sn-glyc-
ero-3-phosphoethanolamine-N-lissamine rhodamine B sulfonyl
(rhodamine-DOPE), which mainly localizes within disordered
domains (Ayuyan and Cohen, 2008). When lipid raft and nonraft
domains coexist, these probes segregate from one another, and
FRET is weak. The temperature dependence of FRET in the Bor-
reliaMLVs was compared to that of Ld state (nonraft) DOPC/cho
vesicles. The BorreliaMLVs show weak FRET (high F/Fo values)Cell Host & Microbe 8, 331–342,at low temperature in contrast to DOPC/
cho (Figure 5F). At high temperature, the
FRET values in the Borrelia MLVs
approach those in DOPC/cholesterol,
showing that the segregation of the
probes in the Borrelia lipid MLVs is lost
at high temperature (Figure 5F). This istypical of the melting of ordered domains at high temperature,
such that ordered domain formation, and segregation of mole-
cules into different domains is lost (Bakht et al., 2007; Xu et al.,
2001). Combined, these results demonstrate that theB. burgdor-
feri lipids have the ability to formordered domains (lipid rafts) that
segregate from Ld domains over a wide range of temperatures.
Temperature Affects Both the Bactericidal Action
of CB2 and Cholesterol Glycolipid Organization
To determine whether the bactericidal effects of CB2 were tem-
perature dependent, we held spirochetes at different tempera-
tures between 4C and 42C and then treated with CB2. The
bactericidal activity of CB2 increased with increasing tempera-
ture (Figure 6A). Additionally, the rate of CB2-induced lysisOctober 21, 2010 ª2010 Elsevier Inc. 337
Figure 6. Modulation of Outer Membrane
Order with Temperature Affects the Bacte-
ricidal Activity of CB2 and the Organization
of the Cholesterol Glycolipids
(A) Killing assay showing that the bactericidal
activity of CB2 is directly proportional to tempera-
ture.
(B) Permeability of theB. burgdorferimembrane is
directly proportional to temperature, as measured
by DPH incorporation (gray diamonds). Lipid
order, asmeasured by anisotropy (black squares),
is inversely proportional to temperature. Results
are from triplicate experiments.
(C) B. burgdorferi were labeled for cholesterol
glycolipids (6 nm colloidal gold) at 4C, 33C,
and 37C and analyzed to observe the native
organization of microdomains and the effect of
temperature on organization and size. At 4C,
the microdomains are greatly enlarged and
cholesterol glycolipids and dispersed. At 33C,
the microdomains exist as distinct clusters of
100 nm; at 37C the microdomains form smaller
(40 nm) clusters. Scale bars represent 100 nm.
Error bars represent the standard deviation. See
also Figure S4.
Cell Host & Microbe
Lipid Rafts in Borrelia and Bactericidal Antibodyincreased as temperature increased (Figures S4A–S4D).
A decrease in the degree of ordered microdomain formation as
temperature increased was also detected by DPH fluorescence.
The intensity of DPH fluorescence bound to B. burgdorferi
increased with increasing temperature (Figure 6B, left y axis),
suggesting that DPH inserts into the membrane of B. burgdorferi
more readily at higher temperatures. In addition, the anisotropy
of DPH fluorescence decreased as temperature increased as
a result of greater membrane disorder (Figure 6B, right y axis).
Anisotropy values of whole B. burgdorferi and their temperature
dependence were concordant with those obtained in model
membranes of B. burgdorferi lipids (Figure 5E). This is consistent
with a decrease in order and a decrease in the raft formation or
size at high temperatures (Fujita et al., 2007).
Indeed, temperature had a significant effect on the organiza-
tion of lipid microdomains in the outer membrane of B. burgdor-
feri (Figure 6C). Cholesterol glycolipids organized into distinct
clusters at 33C (100 nm) and at 37C (40 nm). At 4C larger,
more dispersed clusters were noted. Temperature might alter338 Cell Host & Microbe 8, 331–342, October 21, 2010 ª2010 Elsevier Inc.other membrane properties; however, it
did not affect the levels of several
membrane proteins or the level of CB2
binding to B. burgdorferi (Figure S4E).
The visualization of distinct cholesterol
microdomains (clusters) in the outer
membrane of intact B. burgdorferi cells
is highly indicative of lipid rafts. That the
cholesterol microdomains can be seen
even without antibody treatment indi-
cates that this is the native organization
of the cholesterol glycolipids in the outer
membrane of B. burgdorferi and not the
result of the CB2-induced damage seen
in Figure 4. Furthermore, OspB colocal-izes with the cholesterol glycolipids rafts at different tempera-
tures (Figure 7A), suggesting that this association is maintained
as the size of rafts changes with temperature. Lipid rafts are
also present in spirochetes isolated from ten mouse bladders,
without cultivation, demonstrating that these microdomains
occur in vivo (Figure 7B). That the cholesterol glycolipidmicrodo-
mains are present in vivo suggests that this is the normal organi-
zation of the cholesterol glycolipids when spirochetes are in the
mammalian host. The in vivo organization of the cholesterol
glycolipids is similar to the organization of cultured organisms
at 37C with tight clusters.
DISCUSSION
Three main conclusions are derived from these studies. First, we
show that cholesterol glycolipids of B. burgdorferi are required
for the bactericidal mechanism of CB2, the complement-inde-
pendent IgG against OspB. Second, a cross-reaction with the
cholesterol glycolipids that could have implications for the
Figure 7. Cholesterol Glycolipid Microdomains
Associate with OspB at Different Temperatures
and Exist in B. burgdorferi Harvested Directly
from Mice
(A) B. burgdorferi held at 4C, 33C, or 37C were fixed
and labeled with anti-asialo GM1 (6 nm colloidal gold)
and CB2 (18 nm colloidal gold) followed by secondary
colloidal gold conjugates. OspB in the glycolipid microdo-
mains organize differently depending on the temperature
(boxes).
(B) B. burgdorferi harvested directly (without cultivation)
from the bladders of ten C3H/HeN mice 20 days after
inoculation were labeled for cholesterol glycolipids
(6 nm colloidal gold) to demonstrate the presence of clus-
tering in vivo (boxes).
Scale bars represent 100 nm.
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have also provided evidence for the existence of lipid rafts in
Borrelia from cultures at various temperatures and directly iso-
lated from experimentally infected mice. This has implications
for other prokaryotes.
We demonstrated the requirement of cholesterol and choles-
terol glycolipids for the bactericidal action of CB2. Depletion of
cholesterol and cholesterol glycolipids decreased the bacteri-
cidal activity of CB2, whereas replacement of cholesterol
restored it. Additional evidence for a role of cholesterol in CB2
action comes from the formation and composition of the vesicles
and surface projections that increase upon CB2 exposure. Ultra-
structural and biochemical approaches showed that released
vesicles include the antigen OspB, with bound CB2, and choles-
terol glycolipids in the form of microdomains. Lipid raft organiza-
tion impacts CB2 function. Ultrastructural evidence suggests
that the clustering of the cholesterol glycolipids into distinct
microdomains is maintained in the membrane vesicles and
projections observed after CB2 treatment.
The lipid binding properties of OspB would explain its associ-
ation with these lipid rafts. The structural docking analyses
showed that the cleft of OspB can bind the cholesterol glyco-
lipids in a weak interaction. This could be enhanced by the inter-
action of OspB (and also very likely OspA) with the cholesterol
glycolipids through its covalent palmitoylation at the aminoCell Host & Microbe 8, 331terminal cysteine of the lipoprotein. Binding to
cholesterol, a raft component, could induce
raft association. This could be enhanced by
palmitoylation, which is also believed to impart
an affinity for lipid rafts in eukaryotes (Epand,
2008). The hemagglutinin and neuraminidase
of influenza do not associate with rafts if their
palmitic acids are removed (Shvartsman et al.,
2003; Zhang et al., 2000).
The model for the bactericidal action based
on the evidence presented here requires that
the binding of CB2 toOspB induces an unstable
boundary between microdomains and the
surrounding bilayer resulting in formation of
projections, membrane fission leading to shed-
ding of vesicles rich in cholesterol glycolipidsand OspB, and formation of pores that result in the lysis of the
spirochete (LaRocca et al., 2009). This raises the question as
to how the interaction of OspB with cholesterol glycolipids might
influence membrane fission induced by CB2. One possibility is
that upon CB2 binding, OspB undergoes a conformational
change so that it expands the outer leaflet of the membrane
bilayer. This could result from a penetration of OspB into the
outer leaflet, a net movement of lipid into the outer leaflet from
the inner leaflet, or a decrease in the packing of the outer leaflet
lipids so that they take up more space per molecule. Whatever
the mechanism for the expansion of the outer leaflet, it could
be amplified by the high concentration of OspB within domains
rich in cholesterol glycolipids. Once the outer leaflet expands,
the bilayer would spontaneously bend to maintain contact with
the inner leaflet, thus forming projections. If this bending is suffi-
ciently severe, the boundary between the domains rich in OspB
and the remainder of the membrane would be unstable, leading
to vesiculation from the surface of B. burgdorferi.When OspB is
more dispersed within the membrane, such as when cholesterol
glycolipid is absent, CB2 binding may not cause the same
changes in OspB conformation or membrane structure, thereby
reducing membrane fission (vesiculation). An alternate model is
that membrane disruption could arise from a change in the
OspB-bound lipid upon CB2 binding. For example, the binding
of CB2 could change OspB structure in such a manner that the–342, October 21, 2010 ª2010 Elsevier Inc. 339
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increases, resulting in outer leaflet expansion, which would
have the consequences noted above.
The ultrastructural evidence for the organization of cholesterol
glycolipids into clustered microdomains suggests that these are
analogous to the lipid rafts that form in cholesterol-rich eukar-
oytic cells. The microdomains were 100 nm in diameter at
the optimal in vitro growth temperature for B. burgdorferi
(33C), consistent with the small size of eukaryotic lipid rafts
(Pike, 2009). This evidence was strengthened by biochemical
and biophysical experiments that documented the existence of
a prokaryotic version of lipid raft microdomains. First, we found
that DRMs could be isolated from B. burgdorferi and were rich
in cholesterol glycolipids. OspB, OspA, and P66 were shown
to reside in the DRMs, suggesting that the outer membrane
proteins normally localize in these microdomains. In addition,
the physical behavior of B. burgdorferi lipids in MLVs showed
that they formed lipid raft-like ordered domains as determined
by TX-100 detergent resistance, anisotropy, and FRET. Com-
bined, these data indicate that microdomains form in the outer
membrane of B. burgdorferi and can be considered close
analogs of eukaryotic lipid rafts. Therefore, the discovery that
Borrelia has lipid rafts could be a key to the understanding of
lipoprotein function, to the role of the cholesterol glycolipids
in both physiological and pathological conditions, and to the
pathogenesis of Lyme disease and relapsing fever.
The lack of lipid rafts in the membranes of prokaryotes may be
due to the absence of cholesterol in all but a few bacteria, namely
Helicobacter, Mycoplasma, Ehrlichia, Anaplasma, Brachyspira,
and, of course, Borrelia. We now show that lipid rafts exist in
prokaryotes. These findings represent a substantial shift in the
thinking about lipid rafts, expanding their biological relevance
to prokaryotes.
Lastly, the evolution of the eukaryotic cell membrane with its
well-defined, segregated cholesterol-sphingolipid domains, is
not completely understood. It is possible that prokaryotes,
such as Borrelia, that have ordered lipid domains represent tran-
sitional forms that in the distant past led to the evolution of the
eukaryotic cell membrane. Thus, there is an evolutionary signifi-
cance to the ordered cholesterol-glycolipid domains in the outer
membrane of Borrelia.
Changes in the organization of lipid rafts in B. burgdorferi in
response to temperature may also be of functional importance.
Ultrastructural evidence showed that the microdomains
decrease in size as temperature increases. In fact, spirochetes
harvested directly from mice have lipid rafts that are organized
in the samemanner and size as those from spirochetes in culture
at 37C. Therefore, the in vivo and culture (at 37C) lipid raft orga-
nization is concordant. In addition, biophysical data showing that
membrane order and fluidity decreases as temperature
increases (both in cells and MLVs) are in concordance with the
ultrastructural observations. Furthermore, these changes were
correlated to differences in CB2 bactericidal activity. Lower
temperatures decreased CB2 bactericidal activity, while the
opposite was true for higher temperatures. This is additional
evidence of a link between CB2 action and lipid raft organization.
The temperature dependence of lipid raft organization in
B. burgdorferi may have significant implications in the transmis-
sion cycle of the spirochetes. Due to their arthropod-to-mammal340 Cell Host & Microbe 8, 331–342, October 21, 2010 ª2010 Elsevielife cycle, B. burgdorferi are exposed to a wide range of temper-
atures, from ambient temperature in the tick vector to 37C
during mammalian infection. Thus, lipid raft organization in
Borrelia may change in response to environmental cues and
may play a significant role in their transmission, such as allowing
the spirochetes to sense their location, within the vector or the
mammalian host. The complex of outer membrane lipoproteins
within lipid rafts could carry out a sensor function, and, impor-
tantly, it could have a signaling role in the differential expression
of these lipoproteins as B. burgdorferimoves from the tick to the
mammal.
The cross-reactivity of the antibody to asialo GM1 with lipid
antigens of Borrelia has been known for some time, and anti-
bodies generated against the lipid antigens of B. burgdorferi
cross-react with ganglioside GM1 (Gal-b-1-3-GalNAc-b-1-
4-Gal-b-1-4-Glc-b-1-1-ceramide). We suggest that this cross-
reactivity is partially due to the shared b1-3 linkage of the
galactose (Willison and Kennedy, 1993). That these immuno-
genic glycolipids share an epitope with a prominent host mole-
cule raises the possibility of an antibody-mediated effect in the
pathogenesis of Lyme disease. This idea is not a new one;
however, sufficient evidence for the contribution of autoreactivity
to the pathologic manifestations of Lyme disease has been lack-
ing. The cross-reactivity among the cholesterol glycolipids with
GM1 may prompt a reappraisal of antibody- and cell-mediated
(Kinjo et al., 2006) damage as part of the pathogenesis of the
spirochetoses.
In summary, using an antibody as a biological tool, we have
documented the existence of membrane microdomains in the
membrane of the prokaryote B. burgdorferi. These microdo-
mains contain the cholesterol glycolipids of Borrelia and
contribute to the bactericidal mechanism of CB2. Their lipid
composition and physical properties indicates that they are
similar to the lipid rafts of eukaryotic membranes. Several anti-
gens of B. burgdorferi were shown to reside in lipid rafts, one
of which, OspB, is the target of the complement-independent
bactericidal IgG, CB2.
EXPERIMENTAL PROCEDURES
Bacteria, Cultures, Mice, and Antibodies
B. burgdorferi strain B31 were grown in microaerophillic conditions in BSK-H
medium (Sigma) at 33C. CB2 and CB10 hybridoma supernatants were
obtained as described (Coleman et al., 1992). C3H/HeN mice were inoculated
intradermally with 2 3 104 spirochetes; after 20 days, the bladders from ten
mice were removed and dispersed in Hank’s balanced salt solution (HBSS,
GIBCO). The suspension was centrifuged at 400 3 g, and the supernatant
was examined for spirochetes.
CB2 Bactericidal Assays
So that the effect of cholesterol depletion on the bactericidal mechanism of
CB2 could be tested, B. burgdorferi were treated with MbCD for 30 min in
HBSS, centrifuged, washed, and treated with 2 mg/ml CB2 or CB10 for
15 min followed by dark-field enumeration. CB10 is an IgG1k complement-
dependent antibody to OspA. So that the specificity of MbCD for cholesterol
on CB2 bactericidal activity could be tested, 10 mM MbCD was mixed with
20 mg/ml cholesterol (Invitrogen) for 1 hr and then used to treat spirochetes
for 30 min at 33C . For cholesterol replacement bactericidal assays, spiro-
chetes had their cholesterol depleted, incubated with 20 mg/ml cholesterol
at 33C for 1 hr, harvested by centrifugation, and treated with CB2 or CB10
for 15 min. To add excess cholesterol, spirochetes were incubated with
20 mg/ml cholesterol for 1 hr at 33C followed by treatment with CB2 orr Inc.
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Lipid Rafts in Borrelia and Bactericidal AntibodyCB10 and dark-field enumeration. To test the temperature-dependence and
kinetic assays of the bactericidal effect of CB2, spirochetes were held at
4C, 25C, 33C, 37C, or 42C for 1 hr. For experiments to assess growth
of spirochetes in the presence of excess cholesterol, 10 and 20 mg of choles-
terol in 100% ethanol were added to the cultures; controls consisted of adding
an equal volume of ethanol.
Detection Methods for Lipids and Vesicle Content
B. burgdorferi were depleted of cholesterol and supernatant and pellet were
separated for lipid extraction with choloroform-methanol (1:2) (Bligh and
Dyer, 1959). Extracts (30 ml) were resolved on an HPTLC silica plate (EM sepa-
rations) with chloroform-methanol (85:15) and stained with iodine vapor. Stan-
dards were phosphatidylcholine, phosphatidylglycerol (Avanti Polar Lipids),
and cholesterol (Sigma), as well as known Rf values from identical solvent
systems (Schro¨der et al., 2003; Stu¨bs et al., 2009). MbCD-treated and
untreated supernatant extracts were also analyzed on western blots probed
with rabbit polyclonal antibody to ganglioside asialo GM1 as above.
For detection of cholesterol glycolipids in supernatant vesicles by ELISA,
spirochetes (2.5 3 108/ml in HBSS) with 6% dextran T500 (Pharmacia) were
depleted of cholesterol and treated with 2 mg/ml CB2, CB10, or no antibody
for 30 min at 33C, followed by centrifugation. Supernatants were used to
coat the wells of an ELISA plate, followed by probing with polyclonal rabbit
IgG against asialo GM1 and an alkaline phosphatase conjugated goat anti-
rabbit IgG (1:1000, Sigma) and resolved by the substrate p-nitrophenyl phos-
phate (pNPP, Sigma) at 405 nm in a SpectraMax M2 plate reader.
Supernatants were analyzed by western blot with anti-OspB (mouse IgG1),
anti-OspA (mouse IgG1), and anti-DnaK (mouse IgG1) as a negative control
and resolved with an anti-mouse IgG IR800 conjugate. Reactivity of the immu-
noblots was by scanning in an Odyssey infrared scanner. For all ELISA and
immunoblots, controls included secondary antibody conjugates without the
primary antibody.
Detergent-Resistance of Whole B. burgdorferi
and Model Membrane Vesicles
DRMs were identified and isolated from whole B. burgdorferi by detergent
insolubility and gradient separation using the caveolea/rafts isolation kit
(Sigma) according to the manufacturer’s instructions. For gradient separations
that analyzed the effect of cholesterol depletion/raft disruption, spirochetes
were treated with 10 mMMbCD for 30 min prior to TX-100 treatment. Gradient
fractions were analyzed by slot blot with anti-asialo GM1, CB2, CB10, anti-P66
(rabbit polyclonal IgG), or 1:100 anti-Lon1 protease (rabbit polyclonal IgG). The
secondary antibodies used were anti-rabbit IgG IR800 and anti-mouse IgG
IR800 conjugates. All slot blots were read in an Odyssey infrared scanner.
MLVs were made from ethanolic solutions of lipids and fluorescent probes,
mixed, and dried under nitrogen, redissolved in 20 ml chloroform, and then
redried under nitrogen in high vacuum for 1 hr. The dried lipid film was then
dispersed at 70C in 1 ml PBS (pH 7.4), by vortexing, and cooled to RT.
MLV samples containing 500 mM total lipid (assuming the average molecular
weight of B. burgdorferi lipids was 760 g/mol) were prepared in PBS. Light
scattering at 400 nm was measured at RT with a Beckman 650 spectropho-
tometer. Next, 46 ml 10% v/v Triton X-100/PBS was added, and the samples
were incubated for 2.5 hr at RT. OD at 400 nm was remeasured. Estimated
% detergent resistant lipid was calculated from the ratio of OD remaining after
incubation with detergent to that before detergent addition.
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